ArticlebioRxiv : the preprint server for biology2025
BioLACE: unifying spatial geometry and marker priors for cohesive cell-type clustering in spatial transcriptomics.
Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PRIMER cells: a new weapon in plant immunity research.Die Naturwissenschaften · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Spatial transcriptomics (ST) provides high-dimensional gene expression profiles together with spatial coordinates, enabling the reconstruction of tissue architecture at cellular resolution. While recent graph-based deep learning methods have advanced spatial clustering in ST, many rely on complex architectures that obscure interpretability and rarely integrate biological priors such as marker gene information. We introduce BioLACE, a scalable framework that unifies spatial structure, transcriptomic variation, and curated marker gene profiles within a shared Variational Autoencoder (VAE) latent space. BioLACEjointly optimizes three complementary objectives: (1) a VAE reconstruction loss to preserve transcriptional structure, (2) a graph Laplacian regularizer to enforce spatial smoothness, and (3) a temperature-scaled InfoNCE contrastive loss guided by marker-informed similarities. Applied to MERFISH hypothalamus, mouse spinal cord, and Slide-seq mouse cerebellum datasets, BioLACE achieves superior cell type clustering accuracy, well-defined biologically consistent boundaries, and interpretable latent representations, highlighting its generality and scalability for modern ST analysis. The source code and tutorials for BioLACE are publicly available at https://github.com/maiziezhoulab/BioLACE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.